Mihai Netea

Mihai Netea is a **University Professor** at **Eindhoven University of Technology (TU/e)**, affiliated with the **Department of Biomedical Engineering** and **Precision Medicine**. His research focuses on **immunology and nanomedicine**, particularly targeting myeloid cells for vaccine development, cancer therapy, and managing infection-associated inflammation. He has contributed to advanced nanoparticle platforms for RNA delivery and mTOR pathway modulation in immune cells. His work aligns with UN Sustainable Development Goals related to health and innovation.

Key research interests include **myeloid immunology**, **innate immune responses**, and **nanotechnology-driven therapies**. His recent publications highlight innovations in vaccine design, sepsis treatment, and biomarker discovery for fungal infections.

Netea has collaborated internationally on projects involving **RNA delivery systems**, **immunotherapy**, and **targeted drug delivery**, with notable contributions to Nature Nanotechnology and iScience. Media coverage highlights his work on sepsis therapies and nanomedicine applications.